|
NUPL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.175800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.286400E-02 |
| Normal-vs-Stage2 |
7.480600E-01 |
| Normal-vs-Stage3 |
8.578600E-01 |
| Normal-vs-Stage4 |
6.923000E-01 |
| Stage1-vs-Stage2 |
9.882500E-02 |
| Stage1-vs-Stage3 |
9.559700E-02 |
| Stage1-vs-Stage4 |
5.917600E-01 |
| Stage2-vs-Stage3 |
9.007600E-01 |
| Stage2-vs-Stage4 |
5.801200E-01 |
| Stage3-vs-Stage4 |
6.528400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.635640E-01 |
| Normal-vs-AfricanAmerican |
5.691800E-01 |
| Normal-vs-Asian |
5.366600E-01 |
| Caucasian-vs-AfricanAmerican |
6.100400E-01 |
| Caucasian-vs-Asian |
7.387800E-01 |
| AfricanAmerican-vs-Asian |
6.694000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.931600E-02 |
| Normal-vs-Female |
7.124600E-01 |
| Male-vs-Female |
5.475900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.583800E-01 |
| Normal-vs-Extreme_Weight |
3.521200E-03 |
| Normal-vs-Obese |
8.977200E-01 |
| Normal-vs-Extreme_Obese |
1.936620E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.270590E-01 |
| Normal_Weight-vs-Obese |
4.302600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.554000E-01 |
| Extreme_Weight-vs-Obese |
4.096300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.831000E-01 |
| Obese-vs-Extreme_Obese |
3.982400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.407200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.632600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.479600E-02 |
| Normal-vs-Age(81-100Yrs) |
7.724200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.659600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.562200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.466000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.137800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.315700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.462580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.081800E-02 |
| Normal-VS-Type2 PRCC |
5.711800E-01 |
| Normal-VS-KIRP CIMP |
5.097000E-01 |
| Normal-VS-Unclassified PRCC |
4.936800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.501600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.737800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.096100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.305600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.733200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.870600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.634800E-01 |
| Normal-vs-N1 |
4.444600E-01 |
| Normal-vs-N2 |
5.241500E-03 |
| N0-vs-N1 |
1.763790E-01 |
| N0-vs-N2 |
1.035340E-03 |
| N1-vs-N2 |
4.808600E-04 |
|
|
